Biosafety in Ex Vivo Gene Therapy and Conditional Ablation of Lentivirally Transduced Hepatocytes in Nonhuman Primates

Molecular Therapy - Tập 17 - Trang 1754-1760 - 2009
Olivier Menzel1, Jacques Birraux1,2, Barbara E Wildhaber1,2, Caty Jond1, Françoise Lasne3, Walid Habre4, Didier Trono5, Tuan H Nguyen6, Christophe Chardot1,2
1Research Laboratory of Pediatric Surgery, Department of Microbiology and Molecular Medicine (MIMO), University of Geneva Medical School (CMU), Geneva, Switzerland
2Pediatric Surgery Unit, University of Geneva Children's Hospital, Geneva, Switzerland
3Département des Analyses, Agence Française de Lutte contre le Dopage, Châtenay-Malabry, France
4Pediatric Anesthesia Unit, University of Geneva Children's Hospital, Geneva, Switzerland
5School of Life Sciences, “Frontiers in Genetics” National Center for Competence in Research, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
6INSERM, CIC-04, Biothérapies hépatiques, CHU Hotel Dieu, Nantes, France

Tài liệu tham khảo

Reding, 1999, The pediatric liver transplant program at the Université Catholique de Louvain, Cliniques Saint-Luc, Brussels: overall results in 444 children (1984-1997), Acta Gastroenterol Belg, 62, 285 Kelly, 2006, Current issues in pediatric transplantation, Pediatr Transplant, 10, 712, 10.1111/j.1399-3046.2006.00567.x Burlina, 2004, Hepatocyte transplantation for inborn errors of metabolism, J Inherit Metab Dis, 27, 373, 10.1023/B:BOLI.0000031095.57411.8d Fisher, 2006, Human hepatocyte transplantation: worldwide results, Transplantation, 82, 441, 10.1097/01.tp.0000231689.44266.ac Fox, 2004, Hepatocyte transplantation, J Hepatol, 40, 878, 10.1016/j.jhep.2004.04.009 Dhawan, 2005, Hepatocyte transplantation for metabolic disorders, experience at King's College hospital and review of literature, Acta Gastroenterol Belg, 68, 457 Grossman, 1995, A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia, Nat Med, 1, 1148, 10.1038/nm1195-1148 Naldini, 1996, In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector, Science, 272, 263, 10.1126/science.272.5259.263 Nguyen, 2002, Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes, Mol Ther, 6, 199, 10.1006/mthe.2002.0653 Nguyen, 2006, Ex vivo lentivirus transduction and immediate transplantation of uncultured hepatocytes for treating hyperbilirubinemic Gunn rat, Transplantation, 82, 794, 10.1097/01.tp.0000234675.56598.35 Nguyen, 2005, A simple and highly effective method for the stable transduction of uncultured porcine hepatocytes using lentiviral vector, Cell Transplant, 14, 489, 10.3727/000000005783982828 Lasne, 2004, “Genetic Doping” with erythropoietin cDNA in primate muscle is detectable, Mol Ther, 10, 409, 10.1016/j.ymthe.2004.07.024 Stieger, 2006, Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors, Mol Ther, 13, 967, 10.1016/j.ymthe.2005.12.001 Ghivizzani, 1997, Direct retrovirus-mediated gene transfer to the synovium of the rabbit knee: implications for arthritis gene therapy, Gene Ther, 4, 977, 10.1038/sj.gt.3300486 Xu, 2003, Neonatal or hepatocyte growth factor-potentiated adult gene therapy with a retroviral vector results in therapeutic levels of canine factor IX for hemophilia B, Blood, 101, 3924, 10.1182/blood-2002-10-3050 Andreoletti, 2001, Engraftment of autologous retrovirally transduced hepatocytes after intraportal transplantation into nonhuman primates: implication for ex vivo gene therapy, Hum Gene Ther, 12, 169, 10.1089/104303401750061230 Gupta, 1999, Entry and integration of transplanted hepatocytes in rat liver plates occur by disruption of hepatic sinusoidal endothelium, Hepatology, 29, 509, 10.1002/hep.510290213 Malhi, 2002, Early cell transplantation in LEC rats modeling Wilson's disease eliminates hepatic copper with reversal of liver disease, Gastroenterology, 122, 438, 10.1053/gast.2002.31086 Parouchev, 2006, Efficient ex vivo gene transfer into non-human primate hepatocytes using HIV-1 derived lentiviral vectors, J Hepatol, 45, 99, 10.1016/j.jhep.2006.03.014 Nguyen, 2007, Critical assessment of lifelong phenotype correction in hyperbilirubinemic Gunn rats after retroviral mediated gene transfer, Gene Ther, 14, 1270, 10.1038/sj.gt.3302993 Dagher, 2006, Efficient hepatocyte engraftment in a nonhuman primate model after partial portal vein embolization, Transplantation, 82, 1067, 10.1097/01.tp.0000236103.99456.8f Najimi, 2007, Adult-derived human liver mesenchymal-like cells as a potential progenitor reservoir of hepatocytes, Cell Transplant, 16, 717, 10.3727/000000007783465154 Hacein-Bey-Abina, 2003, A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency, N Engl J Med, 348, 255, 10.1056/NEJM200301163480314 Board of the European Society of Gene and Cell Therapy, 2008, Case of leukaemia associated with X-linked severe combined immunodeficiency gene therapy trial in London, Hum Gene Ther, 19, 3, 10.1089/hum.2007.1221 Bauer, 2008, In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors, Mol Ther, 16, 1308, 10.1038/mt.2008.93 Montini, 2006, Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration, Nat Biotechnol, 24, 687, 10.1038/nbt1216 Nasu, 2007, Suicide gene therapy with adenoviral delivery of HSV-tK gene for patients with local recurrence of prostate cancer after hormonal therapy, Mol Ther, 15, 834, 10.1038/sj.mt.6300096 Traversari, 2007, The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies, Blood, 109, 4708, 10.1182/blood-2006-04-015230 van Dillen, 2002, Influence of the bystander effect on HSV-tk/GCV gene therapy. A review, Curr Gene Ther, 2, 307, 10.2174/1566523023347733 Herraiz, 2003, Liver failure caused by herpes simplex virus thymidine kinase plus ganciclovir therapy is associated with mitochondrial dysfunction and mitochondrial DNA depletion, Hum Gene Ther, 14, 463, 10.1089/104303403321467225 Braun, 2000, Hepatocyte transplantation in a model of toxin-induced liver disease: variable therapeutic effect during replacement of damaged parenchyma by donor cells, Nat Med, 6, 320, 10.1038/73179 Pan, 2007, Prolonged adherence of human immunodeficiency virus-derived vector particles to hematopoietic target cells leads to secondary transduction in vitro and in vivo, J Virol, 81, 639, 10.1128/JVI.01089-06 Canbay, 2003, Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression, Hepatology, 38, 1188, 10.1053/jhep.2003.50472 Clay, 2007, Neuroinvasion of fluorescein-positive monocytes in acute simian immunodeficiency virus infection, J Virol, 81, 12040, 10.1128/JVI.00133-07 Iyoda, 2005, Neutrophils accelerate macrophage-mediated digestion of apoptotic cells in vivo as well as in vitro, J Immunol, 175, 3475, 10.4049/jimmunol.175.6.3475 Nienhuis, 2006, Genotoxicity of retroviral integration in hematopoietic cells, Mol Ther, 13, 1031, 10.1016/j.ymthe.2006.03.001 DePolo, 2000, VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum, Mol Ther, 2, 218, 10.1006/mthe.2000.0116 Seppen, 2003, Long-term correction of bilirubin UDPglucuronyltransferase deficiency in rats by in utero lentiviral gene transfer, Mol Ther, 8, 593, 10.1016/S1525-0016(03)00234-X Bovia, 2003, Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors, Blood, 101, 1727, 10.1182/blood-2001-12-0249 Escarpe, 2003, Development of a sensitive assay for detection of replication-competent recombinant lentivirus in large-scale HIV-based vector preparations, Mol Ther, 8, 332, 10.1016/S1525-0016(03)00167-9 Lasne, 2007, Isoelectric profiles of human erythropoietin are different in serum and urine, Int J Biol Macromol, 41, 354, 10.1016/j.ijbiomac.2007.04.002 Chun, 1997, Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy, Proc Natl Acad Sci USA, 94, 13193, 10.1073/pnas.94.24.13193